All In Biotech

Drug Trial Radar · NCT04634669

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Treatment Resistant Depression

Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

181

Actual

Start

Sep 23, 2020

Primary completion

Feb 18, 2022

Study completion Mar 4, 2022

Sponsor

Lead sponsor
Axsome Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Nov 18, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multi-center, open-label trial to evaluate the long-term safety and efficacy of AXS-05 in subjects with major depressive disorder with prior treatment failures

Conditions

  • Treatment Resistant Depression
  • Major Depressive Disorder

Interventions

  • AXS-05 (dextromethorphan-bupropion)Drug

    \- Titrated to AXS-05 (45 mg dextromethorphan HBr / 105 mg bupropion HCl) twice daily (up to 15 months)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-emergent AEs (TEAEs) Following Dosing With AXS-05Time frame: Duration of participation was up to 15 months. TEAEs were defined as any AE with an onset date in the interval between the first study treatment dosing date and 7 days after the last study treatment dosing date.

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Site

    Little Rock, Arkansas

  • Clinical Research Site

    Redlands, California

  • Clinical Research Site

    Sherman Oaks, California

  • Clinical Research Site

    Upland, California

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami Lakes, Florida

  • Clinical Research Site

    Orlando, Florida

  • Clinical Research Site

    Chicago, Illinois

  • Clinical Research Site

    Boston, Massachusetts

  • Clinical Research Site

    Berlin, New Jersey

  • Clinical Research Site

    Rochester, New York

  • Clinical Research Site

    Staten Island, New York

  • Clinical Research Site

    Hickory, North Carolina

  • Clinical Research Site

    Raleigh, North Carolina

  • Clinical Research Site

    Cincinnati, Ohio

  • Clinical Research Site

    Middleburg Heights, Ohio

  • Clinical Research Site

    Media, Pennsylvania

  • Clinical Research Site

    Dallas, Texas

  • Clinical Research Site

    Friendswood, Texas

  • Clinical Research Site

    Everett, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.